Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 48, 2018 - Issue 4
224
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis of heteroannulated cyclopent[b]indoles: Exploration of in vitro cytotoxicity and molecular docking studies

, , , , &
Pages 447-461 | Received 25 Sep 2017, Published online: 24 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rajendran Satheeshkumar, Lincy Edatt, Aathi Muthusankar, V. B. Sameer Kumar & Karnam Jayarampillai Rajendra Prasad. (2021) Synthesis of Novel Quin[1,2-b]Acridines: In Vitro Cytotoxicity and Molecular Docking Studies. Polycyclic Aromatic Compounds 41:8, pages 1631-1645.
Read now
A. Amuthavalli, B. Prakash, R. Thirugnanasampandan, M. Gogulramnath, G. Bhuvaneswari & R. Velmurugan. (2020) Synthesis, molecular docking, antibacterial, antioxidant, and cytotoxicity activities of novel pyrido-cyclopenta[b]indole analogs. Synthetic Communications 50:8, pages 1176-1189.
Read now

Articles from other publishers (1)

S. O. Rakshin, I. S. Odin, I. M. Sosnin, E. A. Zatynatskiy, G. I. Ostapenko & A. A. Golovanov. (2018) Synthesis and fluorescence properties of nicotinonitrile 1,2,3-triazole derivatives. Russian Chemical Bulletin 67:9, pages 1710-1715.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.